Is it time to abandon the Centrica share price and forget its 9% dividend yield?

Difficult trading for Centrica plc (LON: CNA) could mean it’s one to avoid, despite its large dividend.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

I’ve been concerned about the Centrica (LSE: CNA) share price for a while because the underlying business looks like it is deteriorating. Any doubts I had about that were removed with this month’s release of full-year results.

A worrisome update

The energy and services company’s chief executive, Iain Conn, told us in the report that the firm delivered a “mixed” performance in 2018 “against a challenging external backdrop.” He said volumes in the Spirit Energy and Nuclear businesses “were disappointing” and recovery in the North America business was “slower than expected.”

Looking ahead, he admitted that the firm’s financial performance in 2019 will be affected by the UK default tariff cap “and continuing lower volumes in Exploration & Production (E&P) and Nuclear.” The 2018 to 2020 target range for average adjusted operating cash flow is, therefore, “under some pressure.”

My goodness! That’s a lot of negatives in one update and, naturally, the shares plunged on the day, down around 12.5%. However, that was part of a much larger move lower. Today’s share price around 125p means that since September 2013, the stock has plunged around 70% — ouch!

Out of favour for a reason

But here’s the really disturbing thing. During that entire move down, Centrica has presented us with a high-looking dividend yield and will have attracted many dividend-hunting investors. I think the whole sorry saga underlines the inherent dangers with a dividend-led investing strategy. Generally, high dividend yields mean that a firm is being assigned a low valuation by the stock market and very often that happens for good reasons.

Of course, all investing strategies have their dangers. It’s not always a picnic if you deal in growth shares, or momentum stocks, or micro-caps. But I think there is one thing to keep a close eye on when dabbling with any strategy and that’s the quality of the underlying business.

Centrica doesn’t score well on quality indicators right now. The return-on-capital figure is running just over six and the operating margin a bit below three. Meanwhile, with the market capitalisation at almost £7bn and the enterprise value at more than £11bn, we can see straight away that the firm carries a lot of debt, as we might expect with capital-intensive operations.

The trading record is grim too. Earnings, operating cash flow and the dividend have been trending down over the past five years or so, and that’s exactly opposite to what we want to see from a business supporting our dividend payments. I reckon it’s best to demand that revenue, profits, cash flow and the dividend rise a bit each year before we can be reasonably confident that a dividend-led investment in a company’s shares is secure.

Here’s where I’d invest instead

Cover for Centrica’s forward-looking dividend payments is thin from expected earnings, and I think the dividend looks vulnerable. Any further deterioration in operations could lead to a cut in the payment.

I would abandon the Centrica share price now and forget about the firm’s 9% dividend yield because I don’t want to invest in troubled businesses. I’m not looking for a turnaround, I’m looking for steady growth and a robust and expanding dividend. So I’d rather gain my exposure to firms like Centrica within a FTSE 100 tracker fund where I’m sheltered from single-company risks.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »